Iain Dukes - 09 Jun 2022 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Iain D. Dukes
Issuer symbol
IKNA
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 18:10:16 UTC
Previous filing
23 Dec 2021
Next filing
14 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +13,419 $0.000000 13,419 09 Jun 2022 Common Stock 13,419 $4.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.